<DOC>
	<DOCNO>NCT01010100</DOCNO>
	<brief_summary>The purpose study determine administration small dos Acarbose prevent delay appearance Type 2 Diabetes Mellitus population subject prediabetes .</brief_summary>
	<brief_title>Prevent/Delay Development Type 2 Diabetes Subjects With Impaired Glucose Homeostasis Treated With Acarbose Primary Care</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Age &gt; 40 &lt; 75 year old Men woman Able give voluntary informed consent Existence one follow risk factor : Body Mass Index ( BMI ) &gt; 27 mg/Kg2 One family member diabetes determine anamnesis . Personal antecedent previous blood glucose anomaly ( gestational diabetes revert lactation time , beforeduring surgical stress , fast glycaemia &gt; 110 mg/dL ( 6,1 mM ) &lt; 126 mg/dL ( 7 mM ) register Clinical History last 3 year , etc . ) Previous consumption drug hyperglycaemic capacity period 3 month continuously 6 month discontinuously Type 2 DM Pregnancy study Nursing woman Major debilitate ( e.g . collagen vascular disease , failure major organ , psychosis , severe infection , neutropenia , BMI &lt; 20 mg/Kg2 ) Subjects take prohibit drug ( see protocol ) Subjects take drug impair intestinal motility and/or carbohydrate absorption ( i.e . cholestyramine , neomycin ) Recent cardiovascular event ( within last 6 month ) myocardial infarction , cerebrovascular accident , congestive heart failure Serum creatinine &gt; 2 mg/Dl Fasting triglycerides &gt; 10 mm/L ( &gt; 885 mg/dL ) AST elevation &gt; 2.5 time upper limit normal Subjects hyper/hypothyroidism non compensate Subjects document gastrointestinal disease likely associate abnormal intestinal motility alter absorption nutrient ( e.g . gastroparesia , malabsorption syndrome , chronic diarrhoea state , enteropathy , inflammatory bowel disease , partial intestinal obstruction , large hernia ) Subjects emotional disorder substance abuse ( e.g . severe depression , alcohol drug abuse ) Hypersensitivity Acarbose</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Metabolic Disease</keyword>
	<keyword>IGT Impaired Glucose Tolerance</keyword>
</DOC>